Utilization of Cardiovascular Procedures, Consultation Services, and Cardioprotective Medications Among Type 2 Myocardial Infarction Patients

Background: Coronary atherosclerosis and recurrent cardiovascular events are common among individuals with type 2 myocardial infarction (T2MI). However, cardiovascular resource utilization among T2MI patients is unclear. Objectives: The aim of the study was to characterize cardiovascular resource ut...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Harsh Goel, MD, Meera V. Kapadia, MD, Karan V. Goenka, MD, Caroline M. Schaefer, MPH, Frances L. Revere, PhD, James L. Januzzi, Jr., MD, Saumil S. Datar, MD, Cian P. McCarthy, MB, BCh, BAO, SM, Adwait G. Mehta, MD
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2025-03-01
Rangatū:	JACC: Advances
Ngā marau:	cardioprotective medications diagnostic testing revascularization type 1 myocardial infarction (T1MI) type 2 myocardial infarction (T2MI)
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2772963X25000468
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!